Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ArthroCare v. Ethicon

This article was originally published in The Gray Sheet

Executive Summary

Under an agreement to settle ArthroCare's February 1998 patent infringement suit against Ethicon and subsidiaries Mitek and Gynecare, Ethicon will pay ArthroCare a license fee and ongoing royalties on ArthroCare's U.S. patents in the arthroscopy and gynecology markets, ArthroCare announces June 24. Additional terms of the settlement were not disclosed

You may also be interested in...



Stryker Licenses ArthroCare Coblation Technology Following Serfas Launch

Stryker Corp. agreed to license ArthroCare's Coblation radiofrequency arthroscopy technology just days after its mid-June launch of the competing Serfas arthroscopy product in order to head-off a patent infringement suit, ArthroCare says.

Stryker Licenses ArthroCare Coblation Technology Following Serfas Launch

Stryker Corp. agreed to license ArthroCare's Coblation radiofrequency arthroscopy technology just days after its mid-June launch of the competing Serfas arthroscopy product in order to head-off a patent infringement suit, ArthroCare says.

Arthrocare ReFlex Wand Helps Whip Up 39% Stock Gain In July

Introduction of the ReFlex surgical wand helped conjure up a 39% increase in Arthrocare stock in July. The issue gained 8 points to close the month at 28-1/2.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011993

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel